SCHEMBL22859897

SCHEMBL22859897

CC(C)(C)OC(=O)NC1CC(N2CCOC2=O)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 2/20 0.45
▸ GAA P10253 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ PIK3R1 P27986 1/20 0.42
▸ PIK3CA P42336 1/20 0.42
▸ BTK Q06187 1/20 0.42
▸ NFKB1 P19838 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ HSD11B1 P28845 1/20 0.39
▸ KDM1A O60341 1/20 0.38
▸ MAOB P27338 1/20 0.38
▸ VNN1 O95497 1/20 0.38
▸ MAN2B1 O00754 1/20 0.37
▸ EPHX2 P34913 1/20 0.37
▸ DRD2 P14416 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22859904 0.90 CTSK (0.46) CTSKGAAKMT2AL3MBTL1BTK
SCHEMBL28376416 0.78 CTSK (0.40) CTSKGAAL3MBTL1BTKNFKB1
SCHEMBL28851225 0.74 CTSK (0.46) CTSKGAAKMT2AL3MBTL1PIK3R1
SCHEMBL29066432 0.74 CTSK (0.46) CTSKGAAKMT2AL3MBTL1PIK3R1
SCHEMBL10102987 0.74 CTSK (0.46) CTSKGAAKMT2AL3MBTL1PIK3R1
SCHEMBL2397802 0.74 RECQL (0.50) VNN1
SCHEMBL1116704 0.73 BTK (0.54) CTSKGAAKMT2AL3MBTL1BTK
SCHEMBL962474 0.73 BTK (0.54) CTSKGAAKMT2AL3MBTL1BTK
SCHEMBL29676411 0.73 BTK (0.54) CTSKGAAKMT2AL3MBTL1BTK
SCHEMBL20883087 0.73 KMT2A (0.44) CTSKGAAKMT2AL3MBTL1PIK3R1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021000933-A1 PYRIMIDINONE COMPOUNDS AS CHYMASE INHIBITORS AND APPLICATION THEREOF 南京明德新药研发有限公司 2021-01-07 — — WO disclosed
Send feedback